Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
Website:
http://onkuretherapeutics.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
regular market | Wed, 20 Nov 2024 14:30:00 GMTDividend
Analysts recommendations
Institutional Ownership
Included in screeners
OKUR Latest News
OnKure to host a conference call to review key data presented at SABCS and provide a general corporate update on Friday, December 13, 2024 at 8:00 a.m. ET
What type of business is OnKure Therapeutics?
OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3 kinase alpha harboring the H1047R mutation for the treatment of solid tumors, including breast cancer. The company is headquartered in Boulder, Colorado.
What sector is OnKure Therapeutics in?
OnKure Therapeutics is in the Healthcare sector
What industry is OnKure Therapeutics in?
OnKure Therapeutics is in the Biotechnology industry
What country is OnKure Therapeutics from?
OnKure Therapeutics is headquartered in United States
What is OnKure Therapeutics website?
https://onkuretherapeutics.com
Is OnKure Therapeutics in the S&P 500?
No, OnKure Therapeutics is not included in the S&P 500 index
Is OnKure Therapeutics in the NASDAQ 100?
No, OnKure Therapeutics is not included in the NASDAQ 100 index
Is OnKure Therapeutics in the Dow Jones?
No, OnKure Therapeutics is not included in the Dow Jones index
When was OnKure Therapeutics the previous earnings report?
No data
When does OnKure Therapeutics earnings report?
Next earnings report date is not announced yet